Xinghuo's key technology research on turning and milling machine tools passed the acceptance test

Abstract On November 27, 2009, Tianshui Xinghuo Machine Tool Co., Ltd. undertook the acceptance of the “Key Technology Research on Large-scale CNC Five-axis Linkage Turning and Milling Machine Tool”. This is following the National High Technology Research and Development Program (863...

On November 27, 2009, Tianshui Xinghuo Machine Tool Co., Ltd. undertook the acceptance of the “Key Technology Research on Large-scale CNC Five-axis Linkage Turning and Milling Machine Tool”. This is another national-level major scientific research project completed by Spark Machine Tool Company following the National High Technology Research and Development Program (863 Program) project, a large-scale CNC super-precision Fresnel lens processing equipment.
The acceptance group consisting of 11 experts and scholars from the National Machinery Industry Federation, the National Ministry of Science and Technology, Tsinghua University, Beijing University of Aeronautics and Astronautics and Research Institutes conducted the acceptance of the subject.
The acceptance group experts believe that this project solves the long-term troubled five-axis linkage turning and milling machine tool spindle temperature rise control, C-axis high-precision worm gear worm pair anti-backlash large torque drag, rotary B-axis and large-stroke Y-axis linkage integration, etc. A number of key technical problems, independent research and development of the "SPARK-plus graphical programming system"; has applied for 3 invention patents, obtained 9 utility model patents, formulated 2 revised corporate standards; the subject management norms, research team stability, The expenditure is reasonable; the inspection and acceptance information provided is complete and complete. Unanimously agreed to pass the subject and financial acceptance.  

Azithromycin is manufactured by CSPC OUYI which is the main API product in CSPC OUYI which is the largest azithromycin manufacturer in China with capacity of 600MT per year. The product can meet CP, EP, USP,BP and is qualified by China FDA, US FDA, EDQM, WHO PQ, Indian DCGI, Russia FDA etc and is sold into domestic market and exported into all over the world such as Asia, America, EU, etc. CSPC OUYI is qualified supplier to many world-famous Pharma Groups. Its package is 25kg/fiber drum which can be suitable for domestic and overseas shipment. The azithromycin plant was accepted by all the foreign customers and institutions as most modern API plant. And there is dedicated space in azithromycin plant to micronize the product to meet the different particle size demand from the different customers.

Macrolides Antibiotics Raw Material

CSPC Pharmaceutical Group Limited , http://www.cspcgroup.com